Article

AMD linked with race, study finds

A population-based study showed that white patients are more likely to show signs of age-related macular degeneration than black patients.

Baltimore-A population-based study showed that white patients are more likely to show signs of age-related macular degeneration (AMD) than black patients.

Patients that were aged 65 years and older showed no difference in the prevalence of drusen, based on race. White patients were more likely than blacks to have drusen 64 mm or larger (36% versus 28%), drusen 125 mm or larger (11% versus 5%), and confluent drusen (16% versus 8%) in the central macular zone (p = 0.001 for all), reported Susan Bressler, MD, Wilmer Eye Institute, Johns Hopkins University, and colleagues.

White patients were significantly more likely to have focal hyperpigmentation in the central zone than black patients (7.1% versus 2.5%, p = 0.001), according to the study published in the February issue of the Archives of Ophthalmology.

The results, the researchers said, "suggest that black individuals have similar rates of fundus features in the pericentral zone but do not seem to manifest [AMD] features, particularly those that impart risk for disease progression, in the central zone."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.